Optineurin's Role in Inhibiting NF-κB Activation
Author Information
Author(s): Nagabhushana Ananthamurthy, Bansal Megha, Swarup Ghanshyam
Primary Institution: Centre for Cellular and Molecular Biology, Council of Scientific and Industrial Research, Hyderabad, India
Hypothesis
How does optineurin interact with CYLD to regulate NF-κB activation?
Conclusion
Optineurin is essential for the interaction of CYLD with ubiquitinated RIP, which facilitates the deubiquitination of RIP and negatively regulates TNFα-induced NF-κB activation.
Supporting Evidence
- Optineurin interacts with CYLD to regulate NF-κB activation.
- The H486R mutant of optineurin does not inhibit TNFα-induced NF-κB activation.
- Optineurin knockdown increases levels of ubiquitinated RIP.
- CYLD fails to deubiquitinate RIP in the absence of optineurin.
Takeaway
Optineurin helps another protein, CYLD, to stop a process that can cause inflammation and cell death. If optineurin doesn't work right, it can lead to problems like glaucoma.
Methodology
The study used yeast two-hybrid assays, co-immunoprecipitation, and luciferase reporter assays to analyze the interactions and effects of optineurin and its mutants on NF-κB activation.
Limitations
The study primarily focused on cell line experiments, which may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website